Roche has shared details of…
Roche has shared details of fatalities in its phase 3 [...]
A pair of Sage veterans has…
A pair of Sage veterans has launched a neurology-focused startup [...]
Gene therapy biotech Ray…
Gene therapy biotech Ray Therapeutics has announced the closing of [...]
Gilead and Arcus’ domvanalimab,…
Gilead and Arcus’ domvanalimab, one of the last anti-TIGIT antibodies [...]
Replimune is saying goodbye to a…
Replimune is saying goodbye to a further 161 staffers across [...]
Since its 2014 founding, Zai Lab…
Since its 2014 founding, Zai Lab has built its business [...]
Eli Lilly is picking up its second…
Eli Lilly is picking up its second in vivo CAR-T [...]
Following its move to secure…
Following its move to secure ex-China rights to the CD38-directed [...]
Novo Nordisk is gearing up to…
Novo Nordisk is gearing up to submit its rare blood [...]
Asked by Fierce if he’d consider…
Asked by Fierce if he’d consider returning to the FDA, [...]